Antiretroviral Drug Interactions

Presenter: Kathy Lepik, Research Coordinator, Pharmacovigilance Initiative
BC Centre for Excellence in HIV/AIDS
Facilitator: Dr. Junine Toy, Senior Manager, Drug Treatment Program, BC Centre for Excellence in HIV/AIDS
Share this video:
Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025